BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13

• Press Releases

  Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines

  February 12, 2026

   · 

  11 min read
• Press Releases

  Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026

  February 12, 2026

   · 

  6 min read
• Press Releases

  BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - February 11, 2026

  February 12, 2026

   · 

  1 min read
• Press Releases

  Regeneron Announces Investor Conference Presentations - February 11, 2026

  February 12, 2026

   · 

  1 min read
• Press Releases

  Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

  February 12, 2026

   · 

  1 min read
• Press Releases

  Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025

  February 12, 2026

   · 

  4 min read
• Press Releases

  Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026

  February 12, 2026

   · 

  18 min read
• Press Releases

  QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results

  February 12, 2026

   · 

  22 min read
• Press Releases

  Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

  February 12, 2026

   · 

  18 min read
• Press Releases

  Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results

  February 12, 2026

   · 

  14 min read